Neurodegenerative Diseases News and Research

RSS

Metabolic benefits of Ramadan intermittent fasting revealed: key lipid changes and inflammatory marker improvements

The lipidomic changes during Ramadan diurnal intermittent fasting (RIF) among obese individuals.

17 Oct 2023

Calorie restriction may rejuvenate muscles and activate biological pathways for healthy aging

Reducing overall calorie intake may rejuvenate your muscles and activate biological pathways important for good health, according to researchers at the National Institutes of Health and their colleagues.

13 Oct 2023

UArizona to train next generation of Alzheimer's researchers with prestigious NIH grant

A prestigious National Institute on Aging training grant to develop a future workforce of research scientists in the field of Alzheimer's disease and related dementias was awarded to researchers at the Center for Innovation in Brain Science at the University of Arizona Health Sciences.

11 Oct 2023

Subtle test deficits may predict risk of developing mild cognitive impairment

Among people who report memory and thinking problems, some show no signs of a problem on standard tests, while others have subtle declines on their tests.

11 Oct 2023

Study reveals a microbial metabolite's role in inducing Parkinson's-like symptoms

Researchers from the University of Vienna, University of Konstanz, and Albert Einstein College of Medicine uncover a potential environmental trigger for Parkinson's disease.

11 Oct 2023

New AI model can identify neuroanatomical regions vulnerable to age-related changes

The aging brain undergoes structural and cellular changes that can impact function and increase susceptibility to neurodegenerative disorders like Alzheimer's disease.

11 Oct 2023

Advanced neuroimaging reveals surprising link between glaucoma and Alzheimer's disease

The overlap in clinical and magnetic resonance imaging (MRI) findings between Alzheimer's disease and glaucoma.

9 Oct 2023

Graphene oxide offers a promising new approach to treating Alzheimer's disease

A probable early driver of Alzheimer's disease is the accumulation of molecules called amyloid peptides. These cause cell death, and are commonly found in the brains of Alzheimer’s patients. Researchers at Chalmers University of Technology, have now shown that yeast cells that accumulate these misfolded amyloid peptides can recover after being treated with graphene oxide nanoflakes.

9 Oct 2023

Researchers explore immunomodulating targets for improving glioblastoma therapies

Researchers have delved into the intricate heterogeneity of glioblastoma, a notoriously aggressive brain tumor, using advanced single-cell RNA sequencing and innovative zebrafish avatars. Their findings spotlighted the LGALS1 gene's role in immunosuppression and suggested potential therapeutic avenues for personalized GBM treatment.

8 Oct 2023

Pregnancy hormones 'rewire' the brain to prepare for motherhood, research shows

Researchers at the Francis Crick Institute have shown that pregnancy hormones 'rewire' the brain to prepare mice for motherhood.

5 Oct 2023

Researchers identify new potential treatments for children with rare genetic conditions of blood vessels

A research team at the Francis Crick Institute and Great Ormond Street Hospital (GOSH)/UCL Great Ormond Street Institute of Child Health have identified new potential treatments for children with rare genetic conditions of blood vessels, which cause severe, lifelong, and disabling symptoms like seizures and impaired development.

5 Oct 2023

Groundbreaking research focuses on brain health monitoring, early detection of neurodegenerative diseases

Associate Professor at the University of Oulu Teemu Myllylä, a leading expert in biomedical engineering, recently discussed his team's groundbreaking work in brain health monitoring and early detection of neurodegenerative diseases at the recent 6G-enabled sustainable society event.

4 Oct 2023

Graphene oxide nanoflakes may help treat Alzheimer's disease

A probable early driver of Alzheimer's disease is the accumulation of molecules called amyloid peptides. These cause cell death, and are commonly found in the brains of Alzheimer's patients.

4 Oct 2023

Unveiling the role of astrocyte-derived LCN2 in neurodegenerative disease progression

Researchers reviewed existing data on the neurodegenerative effects of astrocyte-derived lipocalin-2 (LCN-2).

4 Oct 2023

Could seaweeds be the superfood and medicine of the future?

Researchers consolidate the diverse nutritional and medicinal benefits of seaweeds, touting their potential in food, nutraceuticals, and pharmaceuticals. The study also highlights challenges and opportunities in industrial applications, calling for more research to optimize extraction and refinement processes.

2 Oct 2023

New tau PET radiotracer shows promise for early detection of Alzheimer's disease

A new tau PET radiotracer, 18F-SNFT-1, has been found to be more effective than existing tau PET radiotracers in identifying Alzheimer's disease in its earliest stages, according to research published in the September issue of The Journal of Nuclear Medicine.

29 Sep 2023

Insights and new directions in basic, clinical research into neurodegenerative diseases

A special supplement to the Journal of Alzheimer's Disease, published by IOS Press, presents insights and new directions in both basic and clinical research into neurodegenerative diseases.

28 Sep 2023

How do different polyphenol-rich foods impact chronic diseases?

The potential of phytochemicals in promoting a healthy human diet to combat chronic disease.

27 Sep 2023

Research uncovers a link between antiviral drug for COVID-19 and SARS-CoV-2 mutations

Researchers at the Francis Crick Institute, the University of Cambridge, Imperial College London, the University of Liverpool, the University of Cape Town and UKHSA have uncovered a link between an antiviral drug for COVID-19 infections called molnupiravir and a pattern of mutations in the SARS-CoV-2 virus.

25 Sep 2023

Research presents new approach to identify therapeutic targets for human diseases associated with protein phase separation

Recent research demonstrates that protein phase separation (PPS) is widely present in cells and drives a variety of important biological functions.

25 Sep 2023

Neurodegenerative Diseases News and Research

Metabolic benefits of Ramadan intermittent fasting revealed: key lipid changes and inflammatory marker improvements

Calorie restriction may rejuvenate muscles and activate biological pathways for healthy aging

UArizona to train next generation of Alzheimer's researchers with prestigious NIH grant

Subtle test deficits may predict risk of developing mild cognitive impairment

Study reveals a microbial metabolite's role in inducing Parkinson's-like symptoms

New AI model can identify neuroanatomical regions vulnerable to age-related changes

Advanced neuroimaging reveals surprising link between glaucoma and Alzheimer's disease

Graphene oxide offers a promising new approach to treating Alzheimer's disease

Researchers explore immunomodulating targets for improving glioblastoma therapies

Pregnancy hormones 'rewire' the brain to prepare for motherhood, research shows

Researchers identify new potential treatments for children with rare genetic conditions of blood vessels

Groundbreaking research focuses on brain health monitoring, early detection of neurodegenerative diseases

Graphene oxide nanoflakes may help treat Alzheimer's disease

Unveiling the role of astrocyte-derived LCN2 in neurodegenerative disease progression

Could seaweeds be the superfood and medicine of the future?

New tau PET radiotracer shows promise for early detection of Alzheimer's disease

Insights and new directions in basic, clinical research into neurodegenerative diseases

How do different polyphenol-rich foods impact chronic diseases?

Research uncovers a link between antiviral drug for COVID-19 and SARS-CoV-2 mutations

Research presents new approach to identify therapeutic targets for human diseases associated with protein phase separation

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News